David Naumann* and Richard Arikson
The high incidence of chronic kidney disease (CKD) and the rising number of people with end-stage renal disease (ESRD) globally highlight the importance of providing patients with options for renal-replacement therapy methods. Peritoneal dialysis (PD) has been shown in clinical studies to have many benefits as a home-based dialysis therapy, including longer preservation of residual renal function, lower hemodynamic stress, potential for better patient survival, relatively high quality of life, and greater capacity to serve more ESRD patients because of its lower cost and infrastructure needs.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 